0001104659-17-056609.txt : 20170911
0001104659-17-056609.hdr.sgml : 20170911
20170911192242
ACCESSION NUMBER: 0001104659-17-056609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170908
FILED AS OF DATE: 20170911
DATE AS OF CHANGE: 20170911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatt Padmanabh P.
CENTRAL INDEX KEY: 0001539215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 171079887
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 1550 EAST GUDE DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
a4.xml
4
X0306
4
2017-09-08
0
0001356576
SUPERNUS PHARMACEUTICALS INC
SUPN
0001539215
Bhatt Padmanabh P.
C/O SUPERNUS PHARMACEUTICALS, INC.
1550 EAST GUDE DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Sr VP of IP, CSO
Common Stock
2017-09-08
4
S
0
5000
49.8605
D
12500
D
Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 24, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.8500 to $49.9000, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
/s/ Gregory S. Patrick, as attorney-in-fact
2017-09-11